Indeed, following treatment with both of these inhibitors the super-enhancer landscape was substantially changed in NCH644 stem-like GBM cells, which included disruption of super-enhancer regions related to MYC, HK2 and GAPDH, which resulted both in a suppression of mRNA and proteins related to these genes [15]. This evidence concerns the gene MYC and glioblastoma.